Phase 4
Completed N=86
Clinical Comparison of Femoral Nerve Versus Adductor Canal Block Following Anterior Ligament Reconstruction
Source: ClinicalTrials.gov NCT03704376 ↗Enrolled (actual)
86
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcomePrimary: Quadriceps Muscle Activation as Assessed by Surface Electromyography (sEMG) — 266.5; 212.5 microvolts (uV)
◆ Published Evidence
Established
48citations · ~7 / year
Adductor Canal Nerve Versus Femoral Nerve Blockade for Pain Control and Quadriceps Function Following Anterior Cruciate Ligament Reconstruction With Patellar Tendon Autograft: A Prospective Randomized Trial.
Summary
This study will examine the potential differences between femoral nerve blockade (FNB) and adductor canal blockade (ACB) for pain control and quadriceps muscle activation for patients following anterior cruciate ligament (ACL) reconstruction.
Linked Publications (5)
-
Adductor Canal Nerve Versus Femoral Nerve Blockade for Pain Control and Quadriceps Function Following Anterior Cruciate Ligament Reconstruction With Patellar Tendon Autograft: A Prospective Randomized Trial.
-
Platelet-Rich Plasma Augmentation of Meniscal Repair in the Setting of Anterior Cruciate Ligament Reconstruction.
-
Subsequent Surgery for Loss of Motion After Anterior Cruciate Ligament Reconstruction Does Not Influence Function at 2 Years: A Matched Case-Control Analysis.
-
Comparison of Psychological Readiness to Return to Sport After Primary Versus Revision Anterior Cruciate Ligament Reconstruction.
-
Relationship Between Bone Bruise Volume and Patient Outcomes After ACL Reconstruction.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quadriceps Muscle Activation as Assessed by Surface Electromyography (sEMG) |
266.5; 212.5 | — |
| PRIMARY Quadriceps Muscle Activation as Assessed by Surface Electromyography (EMG) |
109.1; 94.1 | — |
| SECONDARY Number of Successful Repetitions With Straight Leg Raise Test |
29.7; 30 | — |
| SECONDARY Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale |
— | — |
| SECONDARY Narcotics Use as Assessed by Morphine Equivalents Consumed |
14.8; 16.0 | — |
Eligibility Criteria
Inclusion Criteria
- Males & Females ages 16-30 yrs
- Undergoing ACL reconstruction by Co-Investigator (Walter Lowe)
- Receiving peri-operative FNB or ACB
Exclusion Criteria
- Not enrolled within the COFAKS study
- Receiving intrathecal nerve blockade or no blockade
Data sourced from ClinicalTrials.gov (NCT03704376) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.